1 / 18

Urology Network Meeting

Urology Network Meeting. Prostate and Bladder Cancer RLU/BGH Joint Clinic . Presented by: Dr Z Malik . Joint Urology Clinic . Clinic began 9 th January 2009 187 patients seen by Dr Malik, Dr Eswar & Dr Robson (as at 04/09/10)

kamea
Download Presentation

Urology Network Meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Urology Network Meeting Prostate and Bladder Cancer RLU/BGH Joint Clinic Presented by: Dr Z Malik

  2. Joint Urology Clinic • Clinic began 9th January 2009 • 187 patients seen by Dr Malik, Dr Eswar & Dr Robson (as at 04/09/10) • 159 patients with Prostate cancer, 28 patients with Bladder cancer

  3. Prostate Cancer ~ Staging n=159

  4. Prostate Cancer ~ Treatment for Tumour n=154

  5. Relevant PSA Before Treatment • Recorded for 133 out of 154 patients with new tumour status Minimum: 0.03 Maximum: 121 Median: 8.2

  6. Prostate Cancer ~ Treatment for Recurrence & Progressive Tumours n=5

  7. Bladder Cancer ~ Staging

  8. Bladder Cancer ~ Treatment 7 patients underwent TURBT between December 2008 and January 2010

  9. Urology Network Meeting Prostate and Bladder Cancers ~ New Referrals to CCO Presented by: Dr Z Malik

  10. Prostate and Bladder Cancer • Referred between 1st August 2009 and 31st July 2010 with new tumour: • 712 prostate • 134 bladder

  11. Prostate Cancer

  12. Referring Hospitals ~ 1st August 2009 to 31st July 2010

  13. Prognostic Groups (UICC 2009)

  14. Prognostic Groups • Group1; Good Prognosis • Group2a; Intermediate Prognosis • Group2b; mainly poor prognosis but includes T2c Gleason 6/low PSA • Group3; T3s, poor prognosis • Group4; T4 and metastatic

  15. South ~ Prognostic Group vs Treatment at CCO(excludes patients who had a prostatectomy)

  16. North ~ Prognostic Group vs Treatment at CCO (excludes patients who had a prostatectomy)

  17. Patients who had a Prostatectomy

  18. North + South ~ Relevant PSA Before Treatment • Recorded 666 out of 712 patients Minimum: 0.13 Maximum: 7960 Median: 11.6

More Related